These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11985472)

  • 1. Structure-activity relationships of a novel class of endothelin-A receptor antagonists and discovery of potent and selective receptor antagonist, 2-(benzo[1,3]dioxol-5-yl)-6-isopropyloxy-4-(4-methoxyphenyl)-2H-chromene-3-carboxylic acid (S-1255). 1. Study on structure-activity relationships and basic structure crucial for ET(A) antagonism.
    Ishizuka N; Matsumura K; Sakai K; Fujimoto M; Mihara S; Yamamori T
    J Med Chem; 2002 May; 45(10):2041-55. PubMed ID: 11985472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel class of endothelin-A receptor antagonists, (R)-2-(benzo[1,3]dioxol-5-yl)-6-isopropyloxy-2H-chromene-3-carboxylic acids (S-1255). Conformational analysis of basic structure, crucial for ET(A) antagonism, in solution and solid states.
    Ishizuka N; Matsumura K; Kikuchi J; Nakai H
    Bioorg Med Chem; 2002 Dec; 10(12):3965-72. PubMed ID: 12413848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic characterization of S-1255, a highly potent and orally active endothelin A receptor antagonist.
    Iwasaki T; Mihara S; Shimamura T; Kawakami M; Masui M; Hayasaki-Kajiwara Y; Naya N; Ninomiya M; Fujimoto M; Nakajima M
    J Cardiovasc Pharmacol; 2001 Apr; 37(4):471-82. PubMed ID: 11300660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6-Carboxy-5,7-diarylcyclopenteno[1,2-b]pyridine derivatives: a novel class of endothelin receptor antagonists.
    Niiyama K; Mase T; Takahashi H; Naya A; Katsuki K; Nagase T; Ito S; Hayama T; Hisaka A; Ozaki S; Ihara M; Yano M; Fukuroda T; Noguchi K; Nishikibe M; Ishikawa K
    Bioorg Med Chem; 2002 Aug; 10(8):2461-70. PubMed ID: 12057635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyrrolidine-3-carboxylic acids as endothelin antagonists. 3. Discovery of a potent, 2-nonaryl, highly selective ETA antagonist (A-216546).
    Liu G; Henry KJ; Szczepankiewicz BG; Winn M; Kozmina NS; Boyd SA; Wasicak J; von Geldern TW; Wu-Wong JR; Chiou WJ; Dixon DB; Nguyen B; Marsh KC; Opgenorth TJ
    J Med Chem; 1998 Aug; 41(17):3261-75. PubMed ID: 9703472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-Activity relationships of 2-substituted 5,7-Diarylcyclopenteno[1,2-b]pyridine-6-carboxylic acids as a novel class of endothelin receptor antagonists.
    Niiyama K; Takahashi H; Nagase T; Kojima H; Amano Y; Katsuki K; Yamakawa T; Ozaki S; Ihara M; Yano M; Fukuroda T; Nishikibe M; Ishikawa K
    Bioorg Med Chem Lett; 2002 Nov; 12(21):3041-5. PubMed ID: 12372497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a series of pyrrolidine-based endothelin receptor antagonists with enhanced ET(A) receptor selectivity.
    Boyd SA; Mantei RA; Tasker AS; Liu G; Sorensen BK; Henry KJ; von Geldern TW; Winn M; Wu-Wong JR; Chiou WJ; Dixon DB; Hutchins CW; Marsh KC; Nguyen B; Opgenorth TJ
    Bioorg Med Chem; 1999 Jun; 7(6):991-1002. PubMed ID: 10428367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-(E)-Styryl-2H-chromene derivatives as potent and selective monoamine oxidase B inhibitors.
    Takao K; Yahagi H; Uesawa Y; Sugita Y
    Bioorg Chem; 2018 Apr; 77():436-442. PubMed ID: 29448189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrrolidine-3-carboxylic acids as endothelin antagonists. 5. Highly selective, potent, and orally active ET(A) antagonists.
    Jae HS; Winn M; von Geldern TW; Sorensen BK; Chiou WJ; Nguyen B; Marsh KC; Opgenorth TJ
    J Med Chem; 2001 Nov; 44(23):3978-84. PubMed ID: 11689084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationship study of first selective inhibitor of excitatory amino acid transporter subtype 1: 2-Amino-4-(4-methoxyphenyl)-7-(naphthalen-1-yl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile (UCPH-101).
    Erichsen MN; Huynh TH; Abrahamsen B; Bastlund JF; Bundgaard C; Monrad O; Bekker-Jensen A; Nielsen CW; Frydenvang K; Jensen AA; Bunch L
    J Med Chem; 2010 Oct; 53(19):7180-91. PubMed ID: 20857912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent and orally active ET(A) selective antagonists with 5,7-diarylcyclopenteno[1,2-b]pyridine-6-carboxylic acid structures.
    Yoshizumi T; Takahashi H; Ohtake N; Jona H; Sato Y; Kishino H; Sakamoto T; Ozaki S; Takahashi H; Shibata Y; Ishii Y; Saito M; Okada M; Hayama T; Nishikibe M
    Bioorg Med Chem; 2004 May; 12(9):2139-50. PubMed ID: 15080914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzofuro[3,2-b]pyridines as mixed ET(A)/ET(B) and selective ET(B) endothelin receptor antagonists.
    Mederski WW; Osswald M; Dorsch D; Christadler M; Schmitges CJ; Wilm C
    Bioorg Med Chem Lett; 1999 Feb; 9(4):619-22. PubMed ID: 10098676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships of cyclic pentapeptide endothelin A receptor antagonists.
    Fukami T; Nagase T; Fujita K; Hayama T; Niiyama K; Mase T; Nakajima S; Fukuroda T; Saeki T; Nishikibe M
    J Med Chem; 1995 Oct; 38(21):4309-24. PubMed ID: 7473559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of 3,4-dihydro-2H-benzo[h]chromene derivatives as potential NF-κB inhibitors.
    Choi M; Hwang YS; Kumar AS; Jo H; Jeong Y; Oh Y; Lee J; Yun J; Kim Y; Han SB; Jung JK; Cho J; Lee H
    Bioorg Med Chem Lett; 2014 Jun; 24(11):2404-7. PubMed ID: 24792464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure activity relationship of 3-nitro-2-(trifluoromethyl)-2H-chromene derivatives as P2Y
    Jung YH; Jain S; Gopinatth V; Phung NB; Gao ZG; Jacobson KA
    Bioorg Med Chem Lett; 2021 Jun; 41():128008. PubMed ID: 33831560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2,4-Diarylpyrrolidine-3-carboxylic acids--potent ETA selective endothelin receptor antagonists. 1. Discovery of A-127722.
    Winn M; von Geldern TW; Opgenorth TJ; Jae HS; Tasker AS; Boyd SA; Kester JA; Mantei RA; Bal R; Sorensen BK; Wu-Wong JR; Chiou WJ; Dixon DB; Novosad EI; Hernandez L; Marsh KC
    J Med Chem; 1996 Mar; 39(5):1039-48. PubMed ID: 8676339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects on haemodynamics by selective endothelin ET(B) receptor and combined endothelin ET(A)/ET(B) receptor antagonism during endotoxin shock.
    Wanecek M; Oldner A; Sundin P; Alving K; Weitzberg E; Rudehill A
    Eur J Pharmacol; 1999 Dec; 386(2-3):235-45. PubMed ID: 10618475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and pharmacological activity of 1,3,6-trisubstituted-4-oxo-1,4-dihydroquinoline-2-carboxylic acids as selective ET(A) antagonists.
    Patel HJ; Olgun N; Lengyel I; Reznik S; Stephani RA
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6840-4. PubMed ID: 20932745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biphenylsulfonamide endothelin receptor antagonists. 4. Discovery of N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]- 2-yl]methyl]-N,3,3-trimethylbutanamide (BMS-207940), a highly potent and orally active ET(A) selective antagonist.
    Murugesan N; Gu Z; Spergel S; Young M; Chen P; Mathur A; Leith L; Hermsmeier M; Liu EC; Zhang R; Bird E; Waldron T; Marino A; Koplowitz B; Humphreys WG; Chong S; Morrison RA; Webb ML; Moreland S; Trippodo N; Barrish JC
    J Med Chem; 2003 Jan; 46(1):125-37. PubMed ID: 12502366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and structure-activity relationships of 2-substituted D-tryptophan-containing peptidic endothelin receptor antagonists: importance of the C-2 substituent of the D-tryptophan residue for endothelin A and B receptor subtype selectivity.
    Fukami T; Yamakawa T; Niiyama K; Kojima H; Amano Y; Kanda F; Ozaki S; Fukuroda T; Ihara M; Yano M; Ishikawa K
    J Med Chem; 1996 Jun; 39(12):2313-30. PubMed ID: 8691426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.